|
1
|
Lee NS, Brewer HB Jr and Osborne JC Jr:
Beta 2-Glycoprotien I: Molecular properties of an unusual
apolipoprotein H. J Biol Chem. 258:4765–4770. 1983.PubMed/NCBI
|
|
2
|
Rand JH, Wu XX, Andree HA, Ross JB,
Rusinova E, Gascon-Lema MG, Calandri C and Harpel PC:
Antiphospholipid antibodies accelerate plasma coagulation by
inhibiting annexin-V binding to phospholipids: A ‘Lupus
Procoagulant’ phenomenon. Blood. 92:1652–1660. 1998.PubMed/NCBI
|
|
3
|
Pittoni V, Ravirajan CT, Donohoe S, Machin
SJ, Lydyard PM and Isenberg DA: Human monoclonal anti-phospholipid
antibodies selectively bind to membrane phospholipid and
beta2-glycoprotein I (beta2-GPI) on apoptotic cells. Clin Exp
Immunol. 119:533–543. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao PJ, Shi Y, Gao YH, Liu YW and Tan Y:
The receptor for beta(2)GP I on membrane of hepatocellular
carcinoma cell line SMMC-7721 is annexin II. World J Gastroenterol.
13:3364–3368. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miyakis S, Lockshin MD, Atsumi T, Branch
DW, Brey RL, Cervera R, Derksen RH, DE Groot PG, Koike T, Meroni
PL, et al: International consensus statement on an update of the
classification criteria for definite antiphospholipid syndrome
(APS). J Thromb Haemost. 4:295–306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pablo Demetrio R, Muñoz P, Hoyos López M,
Calvo V, Riancho L and Taboada Martinez VM: Thrombocytopenia as a
thrombotic risk factor in patients with antiphospholipid antibodies
without disease criteria. Med Clin (Barc). 148:394–400.
2017.PubMed/NCBI
|
|
7
|
Cris JC, Bouvier S, Nouvellon E,
Lissalde-Lavigne G, Mercier E, Balducchi JP and Marès P:
Antiphospholid antibodies and the risk of pregnancy complication.
Thromb Res. 151 Suppl 1:S34–S37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chighizola CB, Raimondo MG and Meroni PL:
Management of thrombotic antiphospholipid syndrome. Semin Thromb
Hemost. Mar 9–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kandiah DA, Sheng YH and Krilis SA: beta
2-Glycoprotein I: Target antigen for autoantibodies in the
‘antiphospholipid syndrome. Lupus. 5:381–385. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dalekos GN, Zachou K and Liaskos C: The
antiphospholipid syndrome and infection. Curr Rheumatol Rep.
3:277–285. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Raschi E, Chighizola CB, Grossi C, Ronda
N, Gatti R, Meroni PL and Borghi MO: β2-glycoprotein I,
lipopolysaccharide and endothelial TLR4: Three players in the two
hit theory for anti-phospholipid-mediated thrombosis. J Autoimmun.
55:42–50. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Robertson SA, Roberts CT, van Beijering E,
Pensa K, Sheng Y, Shi T and Krilis SA: Effect of beta2-glycoprotein
I null mutation on reproductive outcome and antiphospholipid
antibody-mediated pregnancy pathology in mice. Mol Hum Reprod.
10:409–416. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Steinkasserer A, Cockburn DJ, Black DM,
Boyd Y, Solomon E and Sim RB: Assignment of apolipoprotein H (APOH:
beta-2-glycoprotein I) to human chromosome 17q23----qter;
determination of the major expression site. Cytogenet Cell Genet.
60:31–33. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hernández-Ramirez DF, Olivares-Martinez E,
Núñez-Álvarez CA, Chavelas EA, Garcia-Hernandez E, Gómez-Hernandez
G, Llorente L and Cabral AR: The role of β2-glycoprotein I (β2GPI)
carbohydrate chains in the reactivity of anti-β2GPI antibodies from
patients with primary antiphospholipid syndrome and in the
activation and differentiation of U937 cells. Biochem Biophys Res
Commun. 453:94–100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Muzio M, Polentarutti N, Bosisio D, Kumar
Manoj PP and Mantovani A: Toll-like receptor family and signalling
pathway. Biochem Soc Trans. 28:563–566. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gyrd-Hansen M and Meier P: IAPs: From
caspase inhibitors to modulators of NF-kappaB, inflammation and
cancer. Nat Rev Cancer. 10:561–574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xie H, Zhou H, Wang H, Chen D, Xia L, Wang
T and Yan J: Anti-β(2)GPI/β(2)GPI induced TF and TNF-α expression
in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling
pathways. Mol Immunol. 53:246–254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Laat B, Derksen RH, van Lummel M,
Pennings MT and de Groot PG: Pathogenic anti-beta2-glycoprotein I
antibodies recognize domain I of beta2-glycoprotein I only after a
conformational change. Blood. 107:1916–1924. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lutters BC, Derksen RH, Tekelenburg WL,
Lenting PJ, Arnout J and de Groot PG: Dimers of beta 2-glycoprotein
I increase platelet deposition to collagen via interaction with
phospholipids and the apolipoprotein E receptor 2. J Biol Chem.
278:33831–33838. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
De Groot PG and Meijers JC:
β(2)-glycoprotein I: Evolution, structure and function. J Thromb
Haemost. 9:1275–1284. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ailus K, Tulppala M, Palosuo T, Ylikorkala
O and Vaarala O: Antibodies to beta 2-glycoprotein I and
prothrombin in habitual abortion. Fertil Steril. 66:937–941. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vinatier D, Dufour P, Cosson M and Houpeau
JL: Antiphospholipid syndrome and recurrent miscarriages. Eur
Obstet Gynecol Reproduct Biol. 96:37–50. 2001. View Article : Google Scholar
|
|
24
|
Sada PR, Cohen H and Isenberg D: The
pathophysiology of antiphospholipid syndrome. Open Urol Nephrol J.
8:2–9. 2015. View Article : Google Scholar
|
|
25
|
Alijotas-Reig J, Esteve-Valverde E,
Ferrer-Oliveras R, Llurba E and Gris JM: Tumor necrosis
factor-alpha and pregnancy: Focus on biologics. An updated and
comprehensive review. Clin Rev Allergy Immunol. 53:40–53. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Weiss R, Bitton A, Nahary L, Arango MT,
Benhar I, Blank M, Shoenfeld Y and Chapman J: Cross-reactivity
between annexin A2 and Beta-2-glycoprotein I in animal models of
antiphospholipid syndrome. Immunol Res. 65:355–362. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoshimura A: Signal transduction of
inflammatory cytokines and tumor development. Cancer Sci.
97:439–447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ball E, Bulmer JN, Ayis S, Lyall F and
Robson SC: Late sporadic miscarriage is associated with
abnormalities in spiral artery transformation and trophoblast
invasion. J Pathol. 208:535–542. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ferretti C, Bruni L, Dangles-Marie V,
Pecking AP and Bellet D: Molecular circuits shared by placental and
cancer cells, and their implications in the proliferative, invasive
and migratory capacities of trophoblasts. Hum Reprod Update.
13:121–141. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Aardema MW, Oosterhof H, Timmer A, van
Rooy I and Aarnoudse JG: Uterine artery Doppler flow and
uteroplacental vascular pathology in normal pregnancies and
pregnancies complicated by pre-eclampsia and small for gestational
age fetuses. Placenta. 22:405–411. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim YM, Chaiworapongsa T, Gomez R, Bujold
E, Yoon BH, Rotmensch S, Thaler HT and Romero R: Failure of
physiologic transformation of the spiral arteries in the placental
bed in preterm premature rupture of membranes. Am J Obstet Gynecol.
187:1137–1142. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim YM, Bujold E, Chaiworapongsa T, Gomez
R, Yoon BH, Thaler HT, Rotmensch S and Romero R: Failure of
physiologic transformation of the spiral arteries in patients with
preterm labor and intact membranes. Am J Obstet Gynecol.
189:1063–1069. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cui JQ, Shi YF, Zhou HJ and Li JQ: Changes
in gene expression profiles of hydatidiform mole and
choriocarcinoma as compared with trophoblast hyperplasia. Zhonghua
Zhong Liu Za Zhi. 26:727–731. 2004.(In Chinese). PubMed/NCBI
|
